Nexus Pharmaceuticals Announces the Launch of Cyclophosphamide Injection

Nexus Pharmaceuticals, LLC is pleased to announce the commercial launch of Cyclophosphamide Injection, now available in ready-to-dilute 2.5 mL and 5 mL fill multiple-dose vials. As the first AP-rated generic to Dr. Reddy’s, this product reflects our ongoing commitment to expanding access to high-quality, critical care medications that patients and providers depend on.

Cyclophosphamide Injection is available now through your preferred wholesaler or by contacting us directly at (888) 806-4606. For the full announcement, including product NDC information, please visit our press release.

Read the full press release →

About Nexus Pharmaceuticals, LLC

Nexus Pharmaceuticals, LLC, a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they’re needed most.